Last updated 58 days ago

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

478 patients around the world
Available in Spain, Chile, United States
Regeneron Pharmaceuticals
1Research sites
478Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Follicular lymphoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Inmunocel
Recruiting
Av. Pdte. Kennedy 5488, 7630716 Vitacura, Región Metropolitana, Chile
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy